India, with its diverse climatic conditions, is a fertile ground for multiple vector-borne diseases (VBDs). These diseases represent a significant public health challenge, affecting millions annually.
Among the VBDs, malaria, dengue, and chikungunya are the most prevalent. The National Vector Borne Disease Control Programme (NVBDCP) reports over 4 lakh malaria cases annually. Dengue, with its increasing incidence, has been reported in all states, while chikungunya has re-emerged with several outbreaks in the last decade.
VBDs pose a significant burden on India's public health system. They lead to high morbidity and mortality rates, straining health infrastructure and causing substantial economic losses. The indirect impact includes productivity loss due to illness and the social stigma associated with these diseases.
Management of VBDs involves vector control, early case detection, and prompt treatment. Vector control includes environmental management, insecticide-treated nets, and indoor residual spraying. Early case detection and prompt treatment are facilitated by strengthening surveillance systems and improving diagnostic facilities. The NVBDCP plays a crucial role in implementing these strategies.
Despite efforts, controlling VBDs remains a challenge due to factors like urbanization, climate change, and insecticide resistance. Future strategies should focus on integrated vector management, community participation, and leveraging technology for surveillance and vector control. More research is needed to develop effective vaccines and novel vector control methods.
Vector-borne diseases continue to pose a significant public health challenge in India. Comprehensive strategies focusing on prevention, early detection, and prompt treatment are vital. Further, integrating research, policy, and practice can help mitigate the impact of these diseases and improve public health outcomes.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation